Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

TMDXTMDX
Showing 8 of 29 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in TRANSMEDICS GROUP INC

Yes. Citadel Advisors holds 558,824 shares of TMDX (Transmedics Group), worth $37.1M, as of its Q2 2026 13F filing. It increased the position from 61,601 shares in Q1 2026. Citadel Advisors has held TMDX since Q4 2024, across 7 quarterly 13F filings.

Current Value

$37.1M

Current Shares

558,824

Total Value Change

+$37.1M

Total Shares Change

+558,824

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
558,824
+807.2%
$37.1M0.0%$66.42
47
2026-Q1
Decreased
61,601
-57.0%
$6.1M0.0%$99.41
0
2025-Q4
Increased
143,247
+14.7%
$17.4M0.0%$121.65
32
2025-Q3
Decreased
124,917
-20.1%
$14M0.0%$112.20
0
2025-Q2
Decreased
156,441
-74.3%
$21M0.0%$134.01
0
2025-Q1
Increased
609,689
+161.7%
$41M0.0%$67.28
47
2024-Q4
New
232,934
-
$14.5M0.0%$62.35
39
2024-Q3
Exited
0
-100.0%
$00.0%$157.00
0

Other major holders of TMDX: BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used